Skip to Content

Lonza Group Ltd

LONN: XSWX (CHE)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
CHF 497.00TlzlzwMzrhcwpy

Lonza CEO Steps Down; Shares Remain Undervalued for Long-Term Investors

Business Strategy and Outlook

Lonza Group has been a dominant player in the contract development and manufacturing space for decades. We think the outlook for Lonza looks bright, especially as drug manufacturing becomes more complex with biologics and cell and gene therapies playing larger roles in the overall mix.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of LONN so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center